Related Experiment Video
Updated: Jul 16, 2026
05:40
The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
Estradiol valerate and alcohol intake: dose-response assessments
Gina L Quirarte1, Larry D Reid, I Sofía Ledesma de la Teja
1Departamento de Neurobiología Conductual y Cognitiva, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, 76230, México. ginaqui@servidor.unam.mx <ginaqui@servidor.unam.mx>
BMC Pharmacology
|March 6, 2007
Summary
Estradiol valerate (EV) injections can increase female rats' alcohol intake in a dose-dependent manner. This effect, enhancing ethanol consumption, was observed even in female rats without ovaries.
Area of Science:
- Neuroscience
- Endocrinology
- Behavioral Pharmacology
Background:
- Estradiol valerate (EV) is an injectable form of estradiol providing prolonged hormone release.
- Previous studies showed a single 2.0 mg EV injection alters alcohol appetite in female rats.
- This study investigates a wider range of EV doses and their effects in ovariectomized females.
Purpose of the Study:
- To determine the dose-response relationship of estradiol valerate (EV) on alcohol intake in female rats.
- To assess the impact of EV on alcohol consumption in female rats lacking ovaries (ovariectomized).
Main Methods:
- Administered eight different doses of estradiol valerate (EV), ranging from 0.001 to 2.0 mg, to female rats.
- Assessed the effects of a 2.0 mg EV injection on alcohol intake in female rats with ovariectomies.
- Monitored body weight changes and measured estradiol levels in rats with and without a history of alcohol intake.
Main Results:
- Estradiol valerate (EV) administration caused a dose-related decrease in body weight, with recovery within approximately four days.
- Only the highest dose (2.0 mg EV) consistently increased ethanol intake, aligning with previous findings.
- A trend for smaller doses to enhance alcohol intake was observed; ovariectomized rats responded similarly to intact females.
Conclusions:
- Pharmacological doses of estradiol can induce lasting changes, leading to increased alcohol appetite in female rats.
- The observed enhancement of alcohol consumption by estradiol is not dependent on the presence of ovaries.
Related Concept Videos
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
01:23Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...